跳至主要内容
临床试验/EUCTR2009-012738-65-IT
EUCTR2009-012738-65-IT进行中(未招募)不适用

CLINICAL ACTIVITY OF DNA DAMAGING AND NON-DAMAGING CHEMIOTHERAPY REGIMENS IN ADVANCED BREAST CANCER PATIENTS WITH DIFFERENT BIOLOGICAL SUB-TYPES DEFINED BY BIOMARKERS EVALUATION ON CIRCULATING TUMOR CELLS - CTC PLATINUM

AZIENDA USL 4 PRATO0 个研究点开始时间: 2009年5月19日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • ADVANCED BREAST CANCER PATIENTS WHO HAD PROGRESSED ON PRIOR REGIMENS CONTAINING AN ANTRACYCLINE AND/OR TAXANE BASED THERAPY; PATIENTS WITH ECOG PERFORMANCE STATUS OF 0 TO 2; MEASURABLE DISEASE ACCORDING TO RECIST CRITERIA; RENAL, LIVER AND HEMOPOIETIC FUNCTION IN THE LIMITS; PRESENCE OF CTCs IN PERIPHERAL BLOOD SAMPLE; WRITTEN INFORMED CONSENT
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • PRESENCE OF RILEVANT CO-MORBIDITIES; PREGNANT OR LACTATING WOMEN; ALTERED MENTAL STATUS; CONCURRENT ANTI-CANCER THERAPIES OTHER THAN STUDY DRUGS

研究者

发起方
AZIENDA USL 4 PRATO

相似试验